GlaxoSmithKline (GSK) has joined with University of North Carolina at Chapel Hill to pursue HIV cure strategies, The New York Times reports. The HIV Cure center will be established at the university and partner with a venture called Qura Therapeutics, jointly owned by GSK and UNC Chapel Hill. Qura will handle intellectual property, commercialization, manufacturing and governance of the center’s pursuits.
GSK Gives $40 Million to UNC Chapel H... - HFI Connect - Hep...
GSK Gives $40 Million to UNC Chapel Hill to Seek Cure for HIV
Written by
kuzoigwe
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...